Crossmark

Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis

Crossref DOI link: https://doi.org/10.1007/s13300-015-0150-y

Published Online: 2016-01-12

Published Print: 2016-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yavin, Yshai

Mansfield, Traci A.

Ptaszynska, Agata

Johnsson, Kristina

Parikh, Shamik

Johnsson, Eva
Funding

Funding for this research was provided by:

AstraZeneca

Bristol-Myers Squibb
License Information

Text and Data Mining valid from 2016-01-12
More Information

Article History

Received: 18 November 2015

First Online: 12 January 2016